If you have a question or comment related to BU and its response to the COVID-19 crisis, on the subject of the move-out, remote learning, retrieving personal belongings, or anything else, please visit Boston Universitys special COVID-19 website. Questions are being answered there by specific departments in a timely fashion. Thank you. Doug Most, executive editor, BU Today
Even the dogs wont come downstairs.
Number killed in the 9/11 attacks:
2,977
BU-based Boston Playwrights Theatre (BPT) will present a very different Boston Theater Marathon when the annual event begins today, Wednesday, April 1, and it might be just the distraction that all us shut-ins need.
More than 200 Boston-area theater artists are working on Boston Theater Marathon XXII: Special Zoom Edition, which features 10-minute plays written by New England playwrights and presented by New England theater companies. There will be one broadcast every day at noon for more than a month on Zoom, the videoconferencing tool that just about everyone is using to stay in touch these days. Find a complete schedule, with Zoom links, here.
The Elliot Norton Awardwinning marathon, a yearly community-based charity event benefiting the Theatre Community Benevolent Fund, was scheduled for April 19, but was canceled as the coronavirus pandemic escalated earlier this month. Audiences who dial in to the event will be encouraged to donate to participating theater companies and/or to the Theatre Community Benevolent Fund.
We wont let this necessary distancing stop these gifted playwrights and these wonderful companies from coming together to celebrate new work, says BPT and Marathon artistic director Kate Snodgrass (GRS90), a College of Arts & Sciences professor of the practice of playwriting. Theater will continuewhether its on the stage or in our hearts (or rather, in this case, on Zoom). Whether its for 10 minutes or for 10 hours, art lives.
This years Theater Marathon was intended to be a homecoming of sortsthe first time the event had been held at Boston Playwrights Theatre since 2004. (It was at the Huntington Theatre Companys Virginia Wimberly Theatre at the Boston Center for the Arts from 2005 to 2019.) Instead of honoring our past, times dictate that we try something new, says K. Alexa Mavromatis (GRS11), BPT marketing director.
Todays first installment is Three Ladybugs, by Vicki Meagher, sponsored by Boston Playwrights Theatreand featuring an all-BU cast. Its directed by Darren Evans (CAS95), stars Melinda Lopez (GRS00), a CAS adjunct assistant professor of playwriting, as Atheist Ladybug, and veteran Boston stage actors Paula Plum (CFA75) as Agnostic Ladybug and Karen McDonald (CFA72) as Believer Ladybug. Snodgrass and Evans have voice-over parts (Woman and Man) and Mavromatis will read stage directions. Playwrights represented this year include Mavromatis and Ronn Noone (GRS01), as well as local stalwarts like Patrick Gabridge and John Kuntz (GRS05).
The Theater Marathon is traditionally presented as a 10-hour, all-day affair featuring 10-minute plays by 50 New England playwrights and produced by 50 New England theater companies. Instead, this year it will be a daily Zoom-based lunch break through May 17. Readings will begin each day at noon and last approximately 15 minutes. Audiences will need to download the free Zoom app to participate, and it is recommended that they call in a few minutes before curtain time. Nearly every playwright and theater company tapped to participate in the onstage version will be part of the Zoom event.
And yes, the Zoom events will be set up so only the performers are seen and heard.
On Thursday, April 2, all BU alumni, students, faculty, and staff across the globe are asked to wear BU gear for the day and post proudly across social channels using #TerriersTogetheralong with messages of positivity and connection for the BU community. The #TerriersTogether web page asks students and alums to:
The page also offers downloadable Zoom backgrounds so at your next meeting you can make it look like youre at the BU Beach or the GSU.
A couple of BU Today stories we want to be sure you didnt miss: 50 Boston collaborators gathered at the Center for Regenerative Medicine (CReM) on Boston Universitys Medical Campus in March to develop their own FDA-approved coronavirus test. A Questrom supply-chain expert says stock up, yes, but dont panic about food supplies. Also: Former Patriots tight end Rob Gronkowski and model Camille Kostek have donated 10,000 medical-grade KN95 masks to both Boston Medical Center and St. Josephs University Medical Center in New Jersey, in an effort to assist with the high demand for personal protective equipment (PPE) during the pandemic. And finally, if you have followed the conventional wisdom as it evolves toward everybody wear a mask when you go outside, heres how to make your own.
The Massachusetts governor announced Tuesday that he is extending the order closing nonessential businesses and that the state Department of Public Health will keep its stay-at-home advisory in place, both until May 4, matching planned school closures. Gatherings larger than 10 people are also banned. The White House on Sunday extended guidelines for Americans to maintain social distancing through April 30.
An updated list of essential businesses is being distributed. Among the changes: hotels, motels, and short-term rentals like AirBnBs can no longer be booked for leisure purposes. They may be used only for efforts related to fighting COVID-19, like frontline health workers, or for Massachusetts residents who have been otherwise displaced from their residences. People should really be using common sense and not going on vacation right now, Baker said.
The FBI has received multiple reports of conferences being disrupted by pornographic and/or hate images and threatening language, the Boston Globe reports. Apparently, now that were all using Zoom to study and stay connected in an age of social distancing, it has become fertile ground for trolls and hate-mongers. The feds recommend that you use passwords and other Zoom features to prevent disrupters from getting into your work meetings and virtual cocktail parties.
The White House released the epidemiological models of the spread of coronavirus in the United States that painted such a grim picture that President Trump gave up his plan to reopen the country on Easter. Trump warned Americans of a very, very painful two weeks ahead. The models showed the virus is likely to kill 100,000 to as many as 240,000Americans this year. Trump now says social distancing and business closures will continue through April.
A nationwide trial is underway to see if the drug hydroxychloroquine can prevent disease in people exposed to the novel coronavirus. A second trial will test to see if the drug can prevent severe disease in people who are already showing COVID-19 symptoms. Both are run by a University of Minnesota infectious disease specialist.
United States, 174,467; Massachusetts, 6,620.
FindBU Todays latest coverage of the pandemichere. The Universitys hotline for faculty, staff, students, and visiting scholars to call for referral of their virus-related medical concerns is 617-358-4990.
Read the original post:
Coronavirus: BU Wednesday Roundup | BU Today - BU Today
- Advances in regenerative medicine-based approaches for skin ... - March 9th, 2025
- Regenerative Medicine: Case Study for Understanding and Anticipating ... - March 9th, 2025
- Top 3 Grants in Regenerative Medicine: February 2025 - RegMedNet - March 9th, 2025
- Editorial: Tissue Engineering and Regenerative Medicine: Advances, Controversies, and Future Directions by Frontiers in Bioengineering and... - March 9th, 2025
- Malaysia To Host 7th World Conference On Exercise And Regenerative Medicine - BERNAMA - March 9th, 2025
- Advancing Regenerative Medicine: A Comprehensive Outlook on the Global Cell Therapy Market - openPR - March 9th, 2025
- Worlds First 3D-Printed Penis Implant Successfully Restores Function in Pigs and Rabbits - The Daily Galaxy --Great Discoveries Channel - March 9th, 2025
- AskBio Receives FDA Regenerative Medicine Advanced Therapy designation for Parkinsons disease investigational gene therapy - Bayer - February 24th, 2025
- What is Regenerative Medicine? | Regenerative Medicine | University of ... - February 24th, 2025
- The quest for a communication device that tells cells to regenerate the body - Big Think - February 24th, 2025
- Transforming the future of regenerative medicine - Reuters - February 24th, 2025
- Breakthrough Alzheimer's Treatment Gets Official WHO Recognition - Major Milestone for Rare Disease Therapy - StockTitan - February 24th, 2025
- Regenerative Medicine Pioneer with 35-Year Track Record Takes Scientific Helm at ZEO ScientifiX - StockTitan - February 24th, 2025
- 101 Guide to Regenerative Medicine Types | Applications, Challenges - February 7th, 2025
- Regenerative Medicine | What is it? | ASCPM - February 7th, 2025
- Regenerative medicine and advanced therapy | NIST - February 7th, 2025
- Therapeutic Reprogramming toward Regenerative Medicine - February 7th, 2025
- Novel living biomaterial aims to advance regenerative medicine - February 7th, 2025
- UC Irvine-led discovery of new skeletal tissue advances regenerative ... - February 7th, 2025
- Top 3 Grants in Regenerative Medicine: January 2025 - RegMedNet - February 7th, 2025
- Advancements in lung regeneration: from bench to bedside - February 7th, 2025
- Entos Pharmaceuticals Awarded $4 Million USD in Funding from the California Institute for Regenerative Medicine (CIRM) for its Congenital Generalized... - February 7th, 2025
- Adia Nutrition Officially Enters $15.1 Billion Global Stem Cell Market with Domestic Treatments by Successful Opening of First Florida Location -... - February 7th, 2025
- Cell therapy weekly: iPSC therapy IND for Phase III trial cleared - RegMedNet - February 7th, 2025
- Creative Medical Technology Holdings Expands Collaboration with Greenstone Biosciences to Accelerate iPSCelz - EIN News - February 7th, 2025
- Placental Stem Cell Therapy Solution Market Size And Booming - openPR - February 7th, 2025
- Stem Cells Applications in Regenerative Medicine and Disease ... - December 6th, 2024
- Ageing of stem cells reduces their capacity to form tumours - Nature.com - December 6th, 2024
- Master of Science in Regenerative Medicine and Entrepreneurships FUSION program information session - The Daily | Case Western Reserve University - December 6th, 2024
- BioRestorative Therapies Announces Notice of Allowance of - GlobeNewswire - December 6th, 2024
- Stem Cell Therapy Strategic Business Report 2024 - - GlobeNewswire - December 6th, 2024
- University of Colorado Anschutz Medical Campus-Led Team Receives Up to $46 Million to Develop Innovative Treatment to Cure Blindness - University of... - December 6th, 2024
- Affimed Announces Acimtamig and AlloNK Combination Granted Regenerative Medicine Advanced Therapy (RMAT) Designation by the U.S. Food and Drug... - December 6th, 2024
- Navigating the hope and hype of regenerative medicine - October 14th, 2024
- Cell and Gene Therapy Investment Ticks Up After Hard Few Years - BioSpace - October 14th, 2024
- Crackdowns on Unproven Stem Cell Therapies Worked Abroad - Medpage Today - October 14th, 2024
- How Regenerative Medicine can help you get out of pain without surgery - WJLA - October 14th, 2024
- Regenity Biosciences Receives 510(k) Clearance for RejuvaKnee, a Groundbreaking Regenerative Meniscus Implant Device to Redefine the Standard of Care... - October 14th, 2024
- Buy, Sell, Hold: Cell and Gene Therapy - BioPharm International - October 14th, 2024
- Mayo Clinic offers unique regenerative medicine procedure for knee and ... - September 13th, 2024
- Regenerative Medicine to the Rescue - Cleveland Clinic - September 13th, 2024
- Regenerative medicine applications: An overview of clinical trials - September 13th, 2024
- The Progression of Regenerative Medicine and its Impact on Therapy ... - September 13th, 2024
- Immune cell injection significantly boosts healing of bone, muscle & skin - September 13th, 2024
- Regenerative Medicine Foundation - September 13th, 2024
- BridgeBio Receives FDAs Regenerative Medicine Advanced Therapy (RMAT ... - September 13th, 2024
- Tissue engineering and regenerative medicine approaches in colorectal ... - September 13th, 2024
- Tubular scaffolds boost stem cell-driven bone regeneration in skull defects - Phys.org - September 13th, 2024
- Finding the right path(way) to reduce fat accumulation in the liver - Medical University of South Carolina - September 13th, 2024
- NAMRU EURAFCENT Signs Agreement with Egypt Center for Research and Regenerative Medicine - DVIDS - September 13th, 2024
- BridgeBio Receives FDAs Regenerative Medicine Advanced Therapy (RMAT) Designation for BBP-812 Canavan Disease Gene Therapy Program - StockTitan - September 13th, 2024
- BioNexus Gene Lab Corp. Signs Strategic Partnership MOU with Shenzhen Rongguang Group to Advance Cancer Screening, Precision Medicine, and... - September 13th, 2024
- Neurona Therapeutics Receives $3.8 Million CIRM Grant for the Development of Next Generation Neural Cell Therapy Candidate - Yahoo Finance - September 13th, 2024
- Aging is associated with functional and molecular changes in distinct hematopoietic stem cell subsets - Nature.com - September 13th, 2024
- Cellino Awarded $25M in Funding from the Advanced Research Projects Agency for Health (ARPA-H) - Business Wire - September 13th, 2024
- HepaTx Enters Collaboration with Mayo Clinic to Advance Cell Therapy Technology for Liver Disease to Clinical Trials - Longview News-Journal - September 13th, 2024
- Obsidian Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for OBX-115 for the Treatment of Advanced Melanoma -... - September 4th, 2024
- Regenerative Medicine in Orthopedic Surgery: Expanding Our Toolbox - Cureus - September 4th, 2024
- Somite.ai takes pre-seed to $10M as it eyes to become the OpenAI of stem cell biology - CTech - September 4th, 2024
- Longeveron Announces Positive Type C Meeting with U.S. FDA Regarding Pathway to BLA for Lomecel-B in Hypoplastic Left Heart Syndrome (HLHS) - Yahoo... - September 4th, 2024
- Study Explores Potential Of 3D Printed Regenerative Breast Implants - Forbes - September 4th, 2024
- Nikon Announces New Image Analysis Functions to Empower Drug Discovery Research for Cancer, Neurological Disease, and Regenerative Medicine - PR... - September 4th, 2024
- Trinity researcher scores 800,000 to boost regenerative medicine - SiliconRepublic.com - September 4th, 2024
- Seeing the future: Zebrafish regenerates fully functional photoreceptor cells and restores its vision - EurekAlert - September 4th, 2024
- Regenerative Medicine Industry Projected to Surge to USD 73,084.2 Million by 2033, Growing at an 18.5% CAGR - Future Market Insights - September 4th, 2024
- What is regenerative medicine? | Northwell Health - July 2nd, 2024
- Science Saturday: A regenerative reset for aging - July 2nd, 2024
- Science Saturday: A year of new directions and advancements for ... - March 29th, 2024
- Diverse ways regenerative medicine is advancing health care - March 29th, 2024
- Stem cell-based regenerative medicine - PMC - National Center for ... - February 27th, 2024
- Regenerative medicine | NIST - February 10th, 2024
- San Jose blood stem cell donor meets 15-year-old whose life he saved in Los Angeles - The Mercury News - May 17th, 2023
- Regenerative medicine: Current therapies and future directions - April 23rd, 2023
- What Is Regenerative Medicine? | Goals and Applications | ISCRM - April 23rd, 2023
- Important Patient and Consumer Information About Regenerative Medicine ... - April 23rd, 2023
- Regenerative medicine can be a boon for those with Drug-Resistant Tuberculosis - Hindustan Times - April 23rd, 2023
- About Regenerative Medicine - Center for Regenerative ... - Mayo Clinic - April 7th, 2023
- Regenerative Medicine | National Institutes of Health (NIH) - April 7th, 2023
- Porcine Vaccine Market is estimated to be US$ 4.41 billion by 2030 with a CAGR of 7.50%during the forecast - EIN News - April 7th, 2023
- Advancing Safe and Effective Regenerative Medicine Products - March 21st, 2023